GE HealthCare Technologies Inc. (GEHC) Stock Forecast
GEHC analyst forecast
as of October 17, 2026- Analyst consensus
- Buy 4.24 / 5 from 21 analysts
- Price target
- $82.70 average of analyst targets
- Upside to target
- +18.9% from the latest close
- Next earnings
- October 28, 2026 EPS estimate $1.21
- 52-week range
- $59.48 – $88.16
GEHC analyst ratings
21 analystsNumber of analysts at each rating.
GEHC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
GEHC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.21 | $1.18 | $1.25 | $1.07 | +12.8% | 17 |
| Current fiscal year (2026) | $4.93 | $4.78 | $5.00 | $4.59 | +7.3% | 21 |
| Next fiscal year (2027) | $5.41 | $4.92 | $5.64 | $4.93 | +9.8% | 21 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
GEHC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $5.35B | $5.28B | $5.43B | +4.1% | 17 |
| Current fiscal year (2026) | $21.72B | $21.58B | $21.81B | +5.3% | 20 |
| Next fiscal year (2027) | $22.72B | $22.44B | $23.03B | +4.6% | 19 |
GEHC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
GEHC revenue: reported and forecast
GEHC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.24 | $1.20 | $1.20 | $1.20 | $1.21 | −2.7% | 1 up · 0 down |
| Current fiscal year (2026) | $4.87 | $4.93 | $4.93 | $4.93 | $4.93 | +1.1% | 1 up · 0 down |
| Next fiscal year (2027) | $5.36 | $5.41 | $5.41 | $5.41 | $5.41 | +0.9% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
GEHC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; GEHC beat in 10 of 12.
What analysts expect from GEHC
21 analysts cover GE HealthCare; their consensus rating is buy (4.24 on a 1–5 scale, where 5 is a strong buy). The average price target is $82.70, 18.9% above the latest close of $69.57. Analysts expect earnings of $4.93 per share for 2026, +7.3% from a year earlier. For 2027 the average estimate is $5.41 per share on revenue of $22.7 billion. GE HealthCare beat the EPS estimate in 10 of the last 12 quarters.
Related: GEHC income statement, GEHC key metrics, GEHC chart. See the GEHC stock overview for the latest quote and news.
GEHC forecast FAQ
What is GE HealthCare's price target?
The average analyst price target for GE HealthCare is $82.70, 18.9% above the latest close of $69.57.
Is GE HealthCare a buy, hold or sell?
Of 21 analysts covering GE HealthCare, 10 rate it a strong buy, 6 a buy, 5 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is GE HealthCare's EPS forecast?
Analysts forecast $4.93 per share for 2026 (range $4.78 to $5.00); for 2027 the estimate is $5.41.
What is GE HealthCare's revenue forecast?
The average revenue estimate for 2026 is $21.7 billion, growth of 5.3%; for 2027 it is $22.7 billion.
When does GE HealthCare report earnings?
GE HealthCare is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 before the market opens; the EPS estimate is $1.21.
Does GE HealthCare usually beat earnings estimates?
GE HealthCare reported EPS at or above the analyst estimate in 10 of the last 12 quarters.